Unfortunately, even the most accurate ex vivo LTBI assays, which measure IFN-γ release by antigen-stimulated peripheral T cells (Interferon gamma release assays-IGRA), do not distinguish between LTBI and active TB, nor do they provide information on the risk of reactivation and progression to disease (6–8). Here, IFNG is linked to tuberculosis.